Arathi Rajendra

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Background. Current treatment of chronic hepatitis C with pegylated interferon and ribavirin has the ability to eliminate viral infection in about half of the patients treated. Therapeutic options, for those with remaining chronic hepatitis, will remain limited until novel antivirals become available in the future. Consensus interferon is currently(More)
  • 1